Millions face similar challenges, searching for solutions that can truly make a difference
red-flag features such as suspected scarring alopecia or rapidly progressive loss warrant prompt dermatology referral
My team and I have completed over 3,000 Myers cocktail IV and other IV therapy sessions across Pennsylvania, delivering medical-grade care with a consistent five-star rating
Trying to extract a fifth dose from the pen
The formal compound name is Retatrutide and the investigational designation is LY-3437943
Here is a side-by-side comparison based on available trial data: Semaglutide 2.4 mg (Wegovy): 14.9% average weight loss over 68 weeks, GLP-1 receptor agonist only Tirzepatide 15 mg (Zepbound/Mounjaro): 20.9% average weight loss over 72 weeks, dual GLP-1 and GIP agonist Retatrutide 12 mg: 24.2% average weight loss over 48 weeks, triple GLP-1, GIP, and glucagon agonist What I found interesting in the data is that retatrutide appears to produce faster early weight loss than either semaglutide or tirzepatide